Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Hull

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
CJEM|November 21, 2018
New Canadian guideline provides evidence-based approach to non-occupational HIV prophylaxisShannon O'Donnell, Darrell H S Tan, Mark W Hull
Chest|December 9, 2008
Changing global epidemiology of pulmonary manifestations of HIV/AIDSMark W Hull, Peter Phillips, Julio S G Montaner
Current Opinion in HIV and AIDS|October 19, 2012
Optimizing the engagement of care cascade: a critical step to maximize the impact of HIV treatment as preventionMark W Hull, Zunyou Wu, Julio S G Montaner
Current Infectious Disease Reports|July 1, 2016
Update on Current Evidence for Hepatitis C Therapeutic Options in HCV Mono-infected PatientsMark W Hull, Eric M Yoshida, Julio S G Montaner
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 23, 2016
Sexually-transmitted seronegative HCV infection in an HIV-positive post-liver transplant recipient. Case report and review of the literatureFaisal Alshatti, Sarvee Moosavi, Eric M Yoshida, et al.
American Journal of Infection Control|July 11, 2015
Retrospective cohort study of inappropriate piperacillin-tazobactam use for lower respiratory tract and skin and soft tissue infections: Opportunities for antimicrobial stewardshipThomas C Havey, Mark W Hull, Marc G Romney, et al.
Journal of Cutaneous Medicine and Surgery|October 29, 2014
Trichodysplasia spinulosa: rare presentation of polyomavirus infection in immunocompromised patientsMark G Kirchhof, Kam Shojania, Mark W Hull, et al.
The Lancet. Infectious Diseases|October 30, 2016
Achieving the 90-90-90 target: incentives for HIV testingMark A Wainberg, Mark W Hull, Pierre-Marie Girard, et al.
Patient Preference and Adherence|November 10, 2018
Feasibility of vitamin D supplementation interventions to mitigate HIV pre-exposure prophylaxis-related bone mineral density loss: a cross-sectional surveyShaoyuan Wang, Jean-Luc Kortenaar, Mark W Hull, et al.
Current Opinion in HIV and AIDS|January 6, 2010
Epidemiology of treatment failure: a focus on recent trendsMark W Hull, Viviane D Lima, Robert S Hogg, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
CJEM|November 21, 2018
New Canadian guideline provides evidence-based approach to non-occupational HIV prophylaxisShannon O'Donnell, Darrell H S Tan, Mark W Hull
Chest|December 9, 2008
Changing global epidemiology of pulmonary manifestations of HIV/AIDSMark W Hull, Peter Phillips, Julio S G Montaner
Current Opinion in HIV and AIDS|October 19, 2012
Optimizing the engagement of care cascade: a critical step to maximize the impact of HIV treatment as preventionMark W Hull, Zunyou Wu, Julio S G Montaner
Current Infectious Disease Reports|July 1, 2016
Update on Current Evidence for Hepatitis C Therapeutic Options in HCV Mono-infected PatientsMark W Hull, Eric M Yoshida, Julio S G Montaner
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 23, 2016
Sexually-transmitted seronegative HCV infection in an HIV-positive post-liver transplant recipient. Case report and review of the literatureFaisal Alshatti, Sarvee Moosavi, Eric M Yoshida, et al.
American Journal of Infection Control|July 11, 2015
Retrospective cohort study of inappropriate piperacillin-tazobactam use for lower respiratory tract and skin and soft tissue infections: Opportunities for antimicrobial stewardshipThomas C Havey, Mark W Hull, Marc G Romney, et al.
Journal of Cutaneous Medicine and Surgery|October 29, 2014
Trichodysplasia spinulosa: rare presentation of polyomavirus infection in immunocompromised patientsMark G Kirchhof, Kam Shojania, Mark W Hull, et al.
The Lancet. Infectious Diseases|October 30, 2016
Achieving the 90-90-90 target: incentives for HIV testingMark A Wainberg, Mark W Hull, Pierre-Marie Girard, et al.
Patient Preference and Adherence|November 10, 2018
Feasibility of vitamin D supplementation interventions to mitigate HIV pre-exposure prophylaxis-related bone mineral density loss: a cross-sectional surveyShaoyuan Wang, Jean-Luc Kortenaar, Mark W Hull, et al.
Current Opinion in HIV and AIDS|January 6, 2010
Epidemiology of treatment failure: a focus on recent trendsMark W Hull, Viviane D Lima, Robert S Hogg, et al.
Pageof 6